Loading…
Quicksilver Scientific was cited for marketing four products (Nanoemulsified Milk Thistle, Cat's Claw Elite, Nanoemulsified CoQ10, and Liposomal GABA with L Theanine) as drugs without FDA approval by making disease claims on their website that established the products were intended to cure, mitigate, treat, or prevent disease. Specific violations included claims that CoQ10 reduced death from heart disease and fatty liver disease, and that the ingredient could fight pathogens and bacteria—statements that positioned the products as unapproved new drugs under the Federal Food, Drug, and Cosmetic Act. The FDA's review of the company's website in June and September 2021 documented these drug claims, which violated interstate commerce regulations by introducing or delivering the products for such medical uses without proper FDA authorization.